NFKB1 and neoplasm: Mechanistically, these biomarkers act as molecular sentinels, unveiling core regulatory modules within the oxidative stress–inflammation axis that govern tumor progression—including the ROS–NF-κB positive feedback circuitry and NLRP3 inflammasome activation thresholds [254,274].